Uppsala, Sweden

Magnus Thörn

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 2.0

ph-index = 5

Forward Citations = 84(Granted Patents)


Company Filing History:


Years Active: 2011-2020

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Innovative Contributions of Magnus Thorn in Treating Inflammatory Bowel Disease

Introduction

Magnus Thorn is a distinguished inventor based in Uppsala, Sweden, known for his groundbreaking work in treating inflammatory bowel disease (IBD). With a total of two patents to his name, his innovative methods are paving the way for advanced therapeutic approaches in the medical field.

Latest Patents

Magnus Thorn's most recent patents focus on novel treatments for IBD. The first patent details a method involving the collection of regulatory T cells from a patient's sentinel lymph nodes, with the optional activation using cytokines and antigen extracts from inflamed bowel segments. This method also outlines processes for expanding these T cells in vitro and re-infusing them into the patient, along with techniques for obtaining sentinel nodes and re-establishing immune balance in Crohn's disease patients.

The second patent presents a comprehensive method for treating IBD by using an intestinal biopsy from inflamed tissue. This involves mechanically treating the sample to create a cell suspension, identifying activated leukocyte markers, and subsequently employing a column to eliminate activated leukocytes from the bloodstream through a process of antibody immobilization and coupling.

Career Highlights

Magnus Thorn's career is marked by his dedication to advancing healthcare through innovative solutions. As an inventor, his work has garnered attention for its potential to transform the treatment landscape for individuals suffering from IBD. His commitment to research and development has established him as a key figure in the medical field.

Collaborations

In his professional journey, Magnus has collaborated with Ola Winqvist, another notable figure in the industry. Together, they work at Ith Immune Therapy Holdings AB, where their combined expertise drives the innovative research efforts aimed at improving patient outcomes.

Conclusion

Magnus Thorn exemplifies the spirit of innovation in the realm of medical treatment for inflammatory bowel disease. His patented methods demonstrate a significant advancement in therapeutic strategies, showcasing his role as a forward-thinking inventor dedicated to enhancing healthcare. With continued collaboration and research, the potential impact of his work on patients and the medical community is truly promising.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…